·
12 Min Read

Ozempic for weight loss, Zepbound JAMA study, new sickle cell treatments and Medicare payment cuts [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Ozempic for weight loss, sickle cell treatments and more.

series
Chronic Diseases
AMA Update Podcast
·
7 Min Read

AMA in the News: November 2023

Read media highlights mentioning the American Medical Association for November 2023.

series
AMA in the News
AMA in the News
·
9 Min Read

CDC's Antibiotic Awareness Week with Priya Nori, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about antibiotic resistance.

series
Behavioral Health
AMA Update Podcast
AMA Update for Nov. 22, 2023: CDC's Antibiotic Awareness Week with Priya Nori, MD
·
9 Min Read

CDC's Antibiotic Awareness Week with Priya Nori, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about antibiotic resistance.

series
Behavioral Health
AMA Update
·
3 Min Read

AMA strengthens policy to address growing national drug shortages

New policy aimed at diversifying drug manufacturing, supply chains and stabilizing generic drug market to combat drug supply shortages.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Nov. 6, 2023

In the news: FDA handling of drug shortage under investigation, congenital syphilis on the rise, childhood vaccine exemptions hit record high and more.

Publications & Newsletters
Smiling patient in conversation with health care worker
·
4 Min Read

Despite metformin’s benefits for prediabetes, Rx rates lag

Data from 50,000 patients shows that few of those at higher risk are prescribed the drug shown to help prevent progression to diabetes.

Prevention & Wellness
·
1 Min Read

AMA applauds DEA extending telehealth prescription flexibilities through 2024

The AMA applauds the DEA decision to extend flexibilities in the prescribing of controlled substances based on telehealth patient visits through December 31, 2024

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 2, 2023

In the news: "Morning-after pill” for STDs, another updated COVID shot approved, popular weigh loss drugs have rare, but serious risks and more.

Publications & Newsletters